题名 | Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, placebo-controlled, Phase 2 study comparing different dose-escalation schemes |
链接 | https://pubmed.ncbi.nlm.nih.gov/37311722/ |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |